Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

66.35
Delayed Data
As of Sep 30
 +0.17 / +0.26%
Today’s Change
26.80
Today|||52-Week Range
70.92
+47.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues20.0M18.0M20.6M31.3M
 
 
 
 
 
Cost of Goods Sold3.3M3.5M3.4M11.8M
 
 
 
 
 
Depreciation And Amortization2.0M2.1M4.6M6.0M
 
 
 
 
 
 
Operating ExpensesGross Income14.7M12.4M12.5M13.6M
 
 
 
 
 
General Expenses6.2M6.1M6.9M8.4M
 
 
 
 
 
Research And Development815.0K661.0K966.0K764.0K
 
 
 
 
 
Total Operating Expenses11.5M11.8M14.9M26.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income8.5M6.3M5.7M5.2M
 
 
 
 
 
Interest Expense On Debt2.8M2.8M2.8M2.9M
 
 
 
 
 
Other Expenses-28.0K1.0K2.0K-12.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income5.7M3.5M2.9M2.4M
 
 
 
 
 
Income Taxes-1.1M-625.0K-1.5M-1.2M
 
 
 
 
 
Net Income4.5M2.9M1.3M1.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.4M11.4M11.4M11.4M
 
 
 
 
 
Shares To Calculate EPS Diluted11.6M11.6M11.5M11.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.39$0.25$0.12$0.10
 
 
 
 
 
EPS Diluted$0.39$0.25$0.12$0.10